Showing results (71-80 of 632) with videos related to
Sort By:
Pageof 64
Journal of Cardiovascular Pharmacology|January 1, 1995
Regulation of endothelin receptor expression in vascular smooth-muscle cellsJ C Yu, A P DavenportBritish Journal of Pharmacology|August 21, 2013
Evolving pharmacology of orphan GPCRs: IUPHAR CommentaryAnthony P Davenport, Anthony J HarmarCirculation Research|May 1, 1999
Evidence for intracellular endothelin-converting enzyme-2 expression in cultured human vascular endothelial cellsF D Russell, A P DavenportBritish Journal of Pharmacology|March 17, 1999
Endothelin receptor expression and pharmacology in human saphenous vein graftJ J Maguire, A P DavenportBritish Journal of Pharmacology|November 29, 2001
Thromboxane receptor density is increased in human cardiovascular disease with evidence for inhibition at therapeutic concentrations by the AT(1) receptor antagonist losartanS D Katugampola, A P DavenportJournal of Cardiovascular Pharmacology|November 15, 2000
Changes in ET(A)-, AT1- and AT2-receptors in the phenotypically transformed intimal smooth muscle layer of human atherosclerotic coronary arteriesS D Katugampola, A P DavenportBritish Journal of Pharmacology|October 1, 1996
Characterization of the binding of endothelin ETB selective ligands in human and rat heartF D Russell, A P DavenportKidney International|February 1, 1996
Localization of endothelin peptides in human kidneyF E Karet, A P DavenportMolecular Medicine Today|January 1, 1996
Reverse immunogenetics: from HLA-disease associations to vaccine candidatesM P Davenport, A V HillBritish Journal of Pharmacology|September 24, 2004
CRF2 receptors are highly expressed in the human cardiovascular system and their cognate ligands urocortins 2 and 3 are potent vasodilatorsKatherine E Wiley, Anthony P DavenportPageof 64